Total Payments
$93,457
2024 Payments
$3,489
Companies
55
Transactions
842
Medicare Patients
5,810
Medicare Billing
$628,112
Payment Breakdown by Category
Other$69,600 (74.5%)
Food & Beverage$18,836 (20.2%)
Travel$3,878 (4.1%)
Consulting$1,122 (1.2%)
Education$20.89 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $69,600 | 49 | 74.5% |
| Food and Beverage | $18,836 | 775 | 20.2% |
| Travel and Lodging | $3,878 | 14 | 4.1% |
| Consulting Fee | $1,122 | 2 | 1.2% |
| Education | $20.89 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $63,362 | 91 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $12,086 | 56 | $0 (2024) |
| Boston Scientific Corporation | $3,746 | 64 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,185 | 87 | $0 (2024) |
| Amgen Inc. | $1,786 | 144 | $0 (2024) |
| Abbott Laboratories | $1,540 | 34 | $0 (2024) |
| Penumbra, Inc. | $1,150 | 4 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $926.73 | 55 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $862.63 | 15 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $607.71 | 41 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,489 | 94 | Novartis Pharmaceuticals Corporation ($1,457) |
| 2023 | $4,098 | 103 | Penumbra, Inc. ($1,150) |
| 2022 | $1,999 | 87 | Itamar Medical Inc ($290.28) |
| 2021 | $11,269 | 106 | AstraZeneca Pharmaceuticals LP ($6,501) |
| 2020 | $44,256 | 116 | AstraZeneca Pharmaceuticals LP ($36,710) |
| 2019 | $15,570 | 110 | AstraZeneca Pharmaceuticals LP ($13,661) |
| 2018 | $10,533 | 106 | AstraZeneca Pharmaceuticals LP ($5,465) |
| 2017 | $2,243 | 120 | BOSTON SCIENTIFIC CORPORATION ($793.67) |
All Payment Transactions
842 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $15.67 | General |
| Category: Sleep Apnea testing | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: WATCHMAN_IC | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/29/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $150.51 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/21/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $7.88 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.88 | General |
| Category: Cardiovascular | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Consulting Fee | Cash or cash equivalent | $1,090.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | Abbott Laboratories | ASSURITY (Device) | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/08/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $3.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $20.28 | General |
| Category: Cardiovascular Device | ||||||
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $10.07 | General |
| Category: Cardiovascular | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,734 | 3,301 | $514,388 | $193,924 |
| 2022 | 13 | 1,435 | 2,537 | $404,036 | $154,776 |
| 2021 | 14 | 1,351 | 2,384 | $379,780 | $147,389 |
| 2020 | 14 | 1,290 | 2,304 | $356,857 | $132,023 |
Total Patients
5,810
Total Services
10,526
Medicare Billing
$628,112
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 513 | 1,224 | $253,368 | $107,720 | 42.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 171 | 173 | $74,044 | $22,937 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 112 | 112 | $35,616 | $12,724 | 35.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 521 | 1,238 | $39,584 | $12,695 | 32.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 76 | 81 | $32,157 | $10,492 | 32.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 82 | 161 | $22,862 | $9,591 | 42.0% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 52 | 52 | $26,572 | $8,894 | 33.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 34 | 35 | $13,300 | $4,644 | 34.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 18 | 45 | $3,015 | $1,003 | 33.3% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 46 | 46 | $2,346 | $890.56 | 38.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 17 | 17 | $7,276 | $847.61 | 11.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 75 | 76 | $2,280 | $794.37 | 34.8% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 17 | 41 | $1,968 | $691.26 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 456 | 961 | $198,927 | $88,413 | 44.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 162 | 167 | $71,476 | $23,497 | 32.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 105 | 105 | $33,390 | $11,531 | 34.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 471 | 1,017 | $32,544 | $10,510 | 32.3% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2022 | 42 | 42 | $21,462 | $7,060 | 32.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 37 | 38 | $15,086 | $5,600 | 37.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 23 | 23 | $8,740 | $3,096 | 35.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 39 | $5,538 | $2,099 | 37.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2022 | 22 | 43 | $2,881 | $900.38 | 31.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 11 | 11 | $10,065 | $660.65 | 6.6% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2022 | 33 | 33 | $1,683 | $631.84 | 37.5% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2022 | 18 | 28 | $1,344 | $450.50 | 33.5% |
About Dr. Marc Krock, MD
Dr. Marc Krock, MD is a Cardiovascular Disease healthcare provider based in Mckinney, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265496426.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Krock, MD has received a total of $93,457 in payments from pharmaceutical and medical device companies, with $3,489 received in 2024. These payments were reported across 842 transactions from 55 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($69,600).
As a Medicare-enrolled provider, Krock has provided services to 5,810 Medicare beneficiaries, totaling 10,526 services with total Medicare billing of $628,112. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Nuclear Cardiology
- Location Mckinney, TX
- Active Since 04/14/2006
- Last Updated 04/11/2017
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1265496426
Products in Payments
- FARXIGA (Drug) $63,005
- LifeVest (Device) $12,086
- GENERAL THERAPIES (Device) $1,624
- LEQVIO (Drug) $1,536
- Repatha (Biological) $1,206
- Indigo System (Device) $999.67
- Optimizer (Device) $862.63
- ENTRESTO (Drug) $633.29
- XARELTO (Drug) $607.71
- Corlanor (Drug) $552.69
- GALLANT (Device) $523.03
- PRALUENT (Drug) $494.83
- GENERAL - THERAPIES (Device) $492.40
- VERQUVO (Drug) $459.60
- IVUS Systems (Device) $437.65
- MULTAQ (Drug) $431.90
- ELIQUIS (Drug) $406.97
- AVEIR (Device) $392.32
- GENERAL - TACHY (Device) $373.57
- GENERAL TACHY (Device) $353.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Mckinney
Dr. Dale Yoo, M.d, M.D
Cardiovascular Disease — Payments: $814,018
Cardiovascular Disease $814,018
Dr. Muhammad Khan, Md, Facc, Fscai, MD, FACC, FSCAI
Cardiovascular Disease — Payments: $173,883
Cardiovascular Disease $173,883
Dr. Faisal Wahid, M. D, M. D
Cardiovascular Disease — Payments: $77,316
Cardiovascular Disease $77,316
Dr. Wael Abo-Auda, M.d, M.D
Cardiovascular Disease — Payments: $49,936
Cardiovascular Disease $49,936
Dr. Sunil Reddy, M.d, M.D
Cardiovascular Disease — Payments: $43,292
Cardiovascular Disease $43,292
Dr. Han Tan, Md, MD
Cardiovascular Disease — Payments: $28,794
Cardiovascular Disease $28,794